the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories

[Report]

The Pharmaceutical Market: Vietnam

Published: 2008/03

Contact 24 hrs/day
Table of Contents

Abstract

Vietnam' s pharmaceutical market remains chaotic and poorly regulated. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Includes 3 quarterly updated outlook reports!

After years of poor regulation and IP protection, the Vietnamese government has started to gain more control in the the administration of drugs in the market, particularly in the area of price control. The MoH has recently started a crackdown on firms that inflate the price of drugs without prior permission from the Vietnam Drug Administration (VDA), a requirement under the law that was passed in 2005. In 2007, the MoH has come down hard on 13 companies that raised the price of drugs without permission from the VDA, an agency under the MoH, and issued a warning that such firms risk penalties such as fines, or worse still, have their operating licences revoked.

IP laws are still poor, and the Vietnamese drug industry, which has little R&D and makes mainly copycat drugs, supplies 40% of the market. The government is keen to encourage the local industry to supply around 60% of the market, therefore it is not in the best interests of the government to pursue IP laws as aggressively as price control mechanisms. That said, the country' s accession in WTO in 2007 and accordance with the TRIPS agreement has seen the country make strides in the formulation of IP laws and protection, but enforcement remains a problem.

The opening of the economy since the doi moi reforms of the mid-1980s has created a demand for Western drugs which cannot be met by the local industry. Imports, therefore, comprise a significant proportion of the market by value. European suppliers dominate, with the French at the forefront, due to their long historical ties with the region. US manufacturers have only been able to directly supply Vietnam since the lifting of the US government trade boycott in 1994.

Table of Contents

[Report]
The Pharmaceutical Market: Vietnam
Published: 2008/03
Published by : Espicom Business Intelligence Espicom Business Intelligence

Price:
US $ 1,220.00 Hard Copy
US $ 1,220.00 PDF by E-mail (Single User License)
>
Product Code : ES16928
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.